Diabetes Therapy
Diabetes models improve following proangiogenic autologous marrow cell therapy
Published in Obesity and Diabetes Week, May 1st, 2006
According to a study from Japan, "Using Zucker fatty rats, a strain characterized by diabetes and hyperlipidemia, we investigated the diabetes- and hyperlipidemia-related impairment of bone marrow mononuclear cells (BMCs) for inducing therapeutic angiogenesis. BMCs from Zucker fatty and normal Zucker lean rats were collected and cultured."
"Although the characterization and cell survival of BMCs did not differ, the vascular endothelial growth factor (VEGF) production, endothelial differentiation, and endothelial cell colony-forming potential of BMCs from Zucker fatty rats...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Obesity & Sleep Deprivation
Leptin deficiency disrupts the regulation of sleep architecture and diurnal rhythmicity - Obesity Epidemiology
ADRB2 gene accounts for obesity-related phenotypes in males - Obesity Pathogenesis
Adapter p62 is linked to mature-onset obesity and insulin resistance in mouse model - Obesity Therapy
Initial trocar placement is safe and effective in morbidly obese patients - Obesity Therapy
Selective 5-HT2C agonists show promise in obesity treatments - Angiogenesis
Data from angiogenesis program using cell labeling technology reported at conference - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
